TADA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.206600E-01
Normal-vs-Stage2
2.066000E-01
Normal-vs-Stage3
9.170400E-02
Normal-vs-Stage4
9.035800E-01
Stage1-vs-Stage2
2.686600E-01
Stage1-vs-Stage3
1.381960E-01
Stage1-vs-Stage4
8.811800E-01
Stage2-vs-Stage3
2.384400E-01
Stage2-vs-Stage4
2.477800E-01
Stage3-vs-Stage4
2.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.391600E-01
Normal-vs-AfricanAmerican
8.920600E-01
Normal-vs-Asian
6.227800E-01
Caucasian-vs-AfricanAmerican
2.398400E-03
Caucasian-vs-Asian
3.636800E-01
AfricanAmerican-vs-Asian
4.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.771200E-01
Normal-vs-Female
2.764000E-01
Male-vs-Female
8.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.099610E-01
Normal-vs-Age(41-60Yrs)
2.824400E-01
Normal-vs-Age(61-80Yrs)
2.900600E-01
Normal-vs-Age(81-100Yrs)
3.022600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.923800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.772200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.207200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.637200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.519000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.171410E-01
Normal-vs-Daily Drinker
2.894100E-02
Normal-vs-Weekly Drinker
4.074000E-01
Normal-vs-Occasional Drinker
4.123200E-01
Normal-vs-Social Drinker
3.181800E-01
Non Drinker-vs-Daily Drinker
2.358400E-01
Non Drinker-vs-Weekly Drinker
6.529200E-01
Non Drinker-vs-Occasional Drinker
8.528500E-02
Non Drinker-vs-Social Drinker
4.047800E-01
Daily Drinker-vs-Weekly Drinker
2.831200E-01
Daily Drinker-vs-Occasional Drinker
5.864200E-03
Daily Drinker-vs-Social Drinker
7.587900E-02
Weekly Drinker-vs-Occasional Drinker
4.827800E-01
Weekly Drinker-vs-Social Drinker
8.414000E-01
Occasional Drinker-vs-Social Drinker
5.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.346110E-02
Normal-vs-Grade 2
7.365100E-04
Normal-vs-Grade 3
6.815500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.669800E-01
Grade 1-vs-Grade 3
8.021200E-01
Grade 1-vs-Grade 4
1.346110E-02
Grade 2-vs-Grade 3
9.804400E-01
Grade 2-vs-Grade 4
7.365100E-04
Grade 3-vs-Grade 4
6.815500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.589390E-01
Normal-vs-NonDiabetic
2.355800E-01
Diabetic-vs-NonDiabetic
1.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.621620E-01
Normal-vs-NoPancreatitis
2.374600E-01
Pancreatitis-vs-NoPancreatitis
3.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.561000E-01
Normal-vs-N1
1.744010E-01
N0-vs-N1
4.401900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.355600E-01
Normal-vs-TP53-NonMutant
8.199000E-01
TP53-Mutant-vs-TP53-NonMutant
2.886200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
